Acumen Pharmaceuticals Inc
ABOS
Market Cap$142.39M
Close$
$0.11
88.3% downside
Current Fair Value
88.3% downsideOvervalued by 88.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $142.39 Million |
|---|---|
| Enterprise Value | $135.49 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.08 |
| Beta | 0.07 |
| Outstanding Shares | 60,079,778 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.2 |
|---|---|
| PEG | -1.69 |
| Price to Sales | - |
| Price to Book Ratio | 0.33 |
| Enterprise Value to Revenue | 467.22 |
| Enterprise Value to EBIT | -1.46 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Acumen Pharmaceuticals Inc
2,021 employees